Pfizer begins COVID-19 vaccine trial for children under 12


Pfizer Inc. and German partner BioNTech began testing their COVID-19 vaccine in children under 12 with hopes of expanding vaccination to that age range by early 2022, the U.S. drug maker said on Thursday.

View original article here Source

Recommended For You

About the Author: GetFit